Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disease-Modifying Therapies During the COVID-19 Outbreak
Smathorn Thakolwiboon, Hannah Zhao-Fleming, Jie Pan, et al.
International Journal of MS Care (2020) Vol. 22, Iss. 4, pp. 151-157
Open Access | Times Cited: 23

Showing 23 citing articles:

COVID-19 in ocrelizumab-treated people with multiple sclerosis
Richard A. Hughes, L Whitley, Kocho Fitovski, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 49, pp. 102725-102725
Open Access | Times Cited: 78
Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey
Emilio Portaccio, Mattia Fonderico, Bernhard Hemmer, et al.
Multiple Sclerosis Journal (2021) Vol. 28, Iss. 1, pp. 132-138
Open Access | Times Cited: 38
COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
Anne H. Cross, Silvia Delgado, Mario Habek, et al.
Neurology and Therapy (2022) Vol. 11, Iss. 2, pp. 741-758
Open Access | Times Cited: 25
Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
Johann Sellner, Paulus Rommer
Vaccines (2021) Vol. 9, Iss. 2, pp. 99-99
Open Access | Times Cited: 27
Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness
Barbara Barun, Tereza Gabelić, Ivan Adamec, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 48, pp. 102704-102704
Open Access | Times Cited: 32
Impact of the COVID‐19 pandemic on access to healthcare services amongst patients with multiple sclerosis in the Lazio region, Italy
Paola Colais, Silvia Cascini, M Balducci, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 10, pp. 3403-3410
Open Access | Times Cited: 20
COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review
Fioravante Capone, Francesco Motolese, Tiziano Luce, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 48, pp. 102734-102734
Open Access | Times Cited: 19
Associations and Disease–Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review
Altijana Hromić‐Jahjefendić, Debmalya Barh, Cecília Horta Ramalho Pinto, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 910-910
Open Access | Times Cited: 14
Could Sars-Cov2 affect MS progression?
Arianna Di Stadio, Luigina Romani, Evanthia Bernitsas
Multiple Sclerosis and Related Disorders (2020) Vol. 46, pp. 102540-102540
Open Access | Times Cited: 16
Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives
Vikram Bhise, Suhayl Dhib‐Jalbut
Neurotherapeutics (2021) Vol. 18, Iss. 1, pp. 244-251
Open Access | Times Cited: 14
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis
Gianmarco Abbadessa, Luigi Lavorgna, Francesca Trojsi, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 7, pp. 731-743
Closed Access | Times Cited: 13
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point
Simona Toscano, Clara Grazia Chisari, Francesco Patti
Neurology and Therapy (2021) Vol. 10, Iss. 2, pp. 627-649
Open Access | Times Cited: 13
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection
Júlia Leão Batista Simões, Julia Beatrice de Araújo, Margarete Dulce Bagatini
Molecular Neurobiology (2021) Vol. 58, Iss. 10, pp. 5090-5111
Open Access | Times Cited: 12
COVID-19 in Patients with Multiple Sclerosis – A narrative review
Bijay Kumar Shrestha, Eru Sujakhu, Smruti Karale, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 93, pp. 106221-106221
Closed Access | Times Cited: 1
Recurrence of COVID-19 in a Patient With NMO Spectrum Disorder While Treating With Rituximab
Sepideh Paybast, Fereshteh Shahrab, Seyed Amir Hejazi
The Neurologist (2021) Vol. 26, Iss. 6, pp. 281-283
Open Access | Times Cited: 8
Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes
Constanza Segamarchi, Berenice Silva, P. Saidón, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 46, pp. 102449-102449
Open Access | Times Cited: 8
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series
Clara Grazia Chisari, Simona Toscano, Sebastiano Arena, et al.
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians
Klara Dyczkowska, Alicja Kalinowska-Łyszczarz
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 90-100
Open Access | Times Cited: 2
Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era
Jacqueline Nicholas, Robert K. Shin, Enríque Alvarez, et al.
Multiple Sclerosis and Related Disorders (2020) Vol. 49, pp. 102715-102715
Open Access | Times Cited: 4
Disease-Modifying Therapies, Outcomes, Risk Factors and Severity of COVID-19 in Multiple Sclerosis: A MENACTRIMS Registry Based Study
Maya Zeineddine, Amal Al‐Hajje, Pascale Salameh, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 90, pp. 105790-105790
Open Access
Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience
Laura Rosa, Cristiano Scandurra, Alessandro Chiodi, et al.
Journal of Clinical Psychology in Medical Settings (2022) Vol. 29, Iss. 4, pp. 798-807
Open Access | Times Cited: 2
Frequency of Covid-19 Infection and The Disease Profile in Patients Followed with Multiple Sclerosis
Yusuf Ziya Deniz, Mehmet Tecellioğlu, Cemal Özcan
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi (2023) Vol. 19, Iss. 1, pp. 56-62
Open Access
COVID-19 in two patients with multiple sclerosis treated with beta interferons
Karolina Kania, E Tokarz-Kupczyk, Alicja Kalinowska-Łyszczarz
Pharmacotherapy in Psychiatry and Neurology (2021) Vol. 36, Iss. 4, pp. 327-334
Closed Access
Page 1

Scroll to top